This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
medications used for decreasing of increased Lipoprotein(a), CVD risk factor
This page is a summary of: Effects of Rosuvastatin Versus Atorvastatin, Alone or in Combination, on Lipoprotein (a), Annals of Pharmacotherapy, May 2016, SAGE Publications,
DOI: 10.1177/1060028016652415.
You can read the full text:
The following have contributed to this page
Current Cancer Therapy Reviews
The study aims to decipher the molecular mechanisms and pathophysiology of pancreatic cancer with an emphasis on the advances in treatment options and the use of natural products as anticancer agen...
Drug Metabolism and Drug Interactions
The purpose of this investigation was to reaction phenotype the identity of the cytosolic enzyme responsible for the S-oxidation of S-carboxymethyl-L-cysteine (SCMC) in female human hepatic cytosol...
Xenobiotica
An investigation into the post-translational activation of cDNA-expressed human phenylalanine 4-monooxygenase and human hepatic cytosolic fraction phenylalanine 4-monooxygenase activity with respec...
